The prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage (aSAH) remains incompletely elucidated. Furthermore, it is not clear whether these abnormalities impact patient outcomes. The aim of this study was to evaluate the prevalence of pituitary dysfunction after aSAH and its effect on outcomes
Robba, C., Aspide, R., Pegoli, M., Kondratyeva, E., Gritti, P., Fustini, M.f., et al. (2022). Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study. JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 34(1), 44-50 [10.1097/ANA.0000000000000705].
Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study
Bilotta, Federico
2022-01-01
Abstract
The prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage (aSAH) remains incompletely elucidated. Furthermore, it is not clear whether these abnormalities impact patient outcomes. The aim of this study was to evaluate the prevalence of pituitary dysfunction after aSAH and its effect on outcomesFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022 pITUTdYSFsah-JNA2020.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
4.17 MB
Formato
Adobe PDF
|
4.17 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
